SLC47A1 and hyperuricemia: Since Mate1 is a key transporter to explain pharmacokinetic alterations of tested drugs by hyperuricemia, the protein level of kidney Mate1 in hyperuricemia was measured, and the significant decrease to 60.5% of normal rats was observed (Fig 5), which is comparable with the change in mRNA expression (Fig 2).